The Vaccine Compensation Court
In the United States, if a person is harmed by a product, they have the right to seek compensation through the judicial system. This is not the case for those injured by vaccines. In the 1980’s, lawsuits against vaccine manufacturers and medical providers began to rise. Vaccine companies responded by claiming they would stop making vaccines because they were not making profits…
Should We Be Concerned About Vaccines Made in China?
The past few weeks, there have been a series of news reports coming out of China revealing that thousands of doses of improperly stored and expired vaccines for children and adults were illegally sold for millions of dollars on the black market by more than 100 people associated with…
What is Peer Review of Medical Research Papers?
The aim of scientific research is to improve medical knowledge and find better ways to treat disease. As part of this process, publication in the medical journals enables the wider scientific community to share developments, and to test findings and take them further. Peer review is…
Pyriproxyfen Suspected of Causing Microcephaly in Brazil
A report published by Médicos de Pueblos Fumigados (Physicians in the Crop-Sprayed Villages) of Argentina on February 3, 2016 discounts the theory that the growth in the number of cases of babies born with microcephaly in Brazil during the past year are due to the Zika virus transmitted…
GSK Business Strategy Based on Selling Lots of Vaccines
In its latest effort to increase its sales volume for vaccines and other pharmaceutical products, GlaxoSmithKline (GSK) of Great Britain has officially launched GSKDirect, described as a new “e-commerce platform that simplifies the way customers order vaccines and pharmaceutical…
U.S. Vaccine Market Forecast at $17.4 Billion by 2018
The value of the market for vaccines in the United States will reach $17.4 billion in 2018, according to a study published by Transparency Market Research of Albany, NY. If accurate, the projection would represent a compound annual growth rate (CAGR) of 5.3% during 2012-2018. TMR estimated the US vaccine market at $12.8 billion in 2012. TMR attributes its optimistic forecast to…